CSC
UTMD icon

Cove Street Capital’s Utah Medical Products UTMD Stock Holding History

Cove Street Capital’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$5.48K Hold
87
– – 0.01% 93
2025
Q2 		$4.95K Hold
87
– – 0.01% 96
2025
Q1 		$4.88K Hold
87
– – 0.01% 94
2024
Q4 		$5.35K Buy
+87
New +$5.63K 0.01% 94

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Cove Street Capital's UTMD Position: Q3 2025 in Review

Cove Street Capital held its Utah Medical Products (UTMD) position steady in Q3 2025 at 87 shares worth $5.48K. The position accounts for 0.01% of the portfolio, ranked #93.

Cove Street Capital first reported a position in UTMD in Q4 2024 and has held it in 4 quarters since. 117 funds tracked by Wall St. Rank hold UTMD as of Q3 2025.

  • Cove Street Capital held 87 shares of Utah Medical Products worth $5.48K as of Q3 2025.
  • Cove Street Capital left its Utah Medical Products share count unchanged in Q3 2025.
  • Utah Medical Products made up 0.01% of Cove Street Capital's portfolio in Q3 2025, its #93 holding.
  • Cove Street Capital first reported a position in Utah Medical Products in Q4 2024 and has held it in 4 quarters since.
  • 117 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2025.

Based on Cove Street Capital's 13F filing for Q3 2025, filed 13 Nov 2025.